Price T Rowe Associates Inc View Ray, Inc. Transaction History

Price T Rowe Associates Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.35 - $3.28 $565 - $5,303	1,617 Added 5.89%	29,092 $11,000
Q1 2023 May 15, 2023	BUY	$3.28 - $4.81 $4,729 - $6,936	1,442 Added 5.54%	27,475 $96,000
Q4 2022 Feb 14, 2023	BUY	$3.65 - $4.82 $10,654 - $14,069	2,919 Added 12.63%	26,033 $117,000
Q3 2022 Nov 14, 2022	BUY	$2.66 - $3.97 $23,410 - $34,939	8,801 Added 61.49%	23,114 $85,000
Q2 2022 Aug 15, 2022	BUY	$2.42 - $4.05 $2,420 - $4,050	1,000 Added 7.51%	14,313 $38,000
Q1 2022 May 16, 2022	BUY	$3.45 - $5.83 $45,929 - $77,614	13,313 New	13,313 $52,000
Q4 2021 Feb 14, 2022	SELL	$4.89 - $7.59 $56,577 - $87,816	-11,570 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$3.94 - $6.75 $45,585 - $78,097	11,570 New	11,570 $76,000

645K

50K

30K

Ticker VRAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 181,010,000
Market Cap $1.81M
Description
ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin tox...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.